JESSICA HALL: Open Payments
NPI 1386084655 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,964 in 179 payments from 20 companies in 2025. Trend: 2023 $5,512 · 2024 $3,450 · 2025 $4,964
Food & beverage: $3,732Consulting: $1,140Education: $92
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 18 | $1,581 |
| Arcutis Biotherapeutics, Inc. | 10 | $467 |
| Regeneron Healthcare Solutions, Inc. | 15 | $392 |
| ABBVIE INC. | 27 | $387 |
| Janssen Biotech, Inc. | 18 | $282 |
| Incyte Corporation | 11 | $220 |
| Amgen Inc. | 14 | $220 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $215 |
| GENZYME CORPORATION | 8 | $160 |
| Novartis Pharmaceuticals Corporation | 7 | $155 |
Products named: Bimzelx, DUPIXENT, Zoryve, SKYRIZI, TREMFYA, OPZELURA, OTEZLA, COSENTYX.
Industry payments across SC — which companies pay providers there.
